[Asia Economy Reporter Lee Seon-ae]
▲Hyundai Motor Company=Purchased 50 billion KRW worth of MMT from affiliate Hyundai Motor Securities for stable fund management and profitability enhancement
▲SK Bioscience=Applied for Phase 3 clinical trial plan in Colombia for heterologous booster shot of COVID-19 vaccine GBP510
▲Isu Chemical=Decided on spin-off of business divisions for manufacturing and sales of fine chemical products and all-solid-state battery materials
▲Iljin Materials=Loaned 52 billion KRW to affiliate IM Technology
▲SK Innovation=Subsidiary BlueOvalSK decided on a 501.5 billion KRW rights offering
▲Kumho Electric=Decided to acquire 2 billion KRW worth of shares in affiliate Brickmate and to sell 5.1 billion KRW worth of own convertible bonds
▲Geumyang=Submitted a purchase commitment letter to the Busan City industrial complex development project operator for securing land for secondary battery manufacturing
▲Jahwa Electronics=Signed a share transfer agreement for the local Chinese subsidiary; contract amount to be negotiated later
▲Kukbo=Changed largest shareholder to M Real Estate Growth No.1 Investment Purpose LLC with 20.74% stake; existing largest shareholder KB Kukbo’s stake decreased from 6.23% to 4.94%
▲SK Square=Invested 8.3 billion KRW in affiliate SK Telecom CST1
▲Samsung Life Insurance=Pre-set a short-term borrowing limit of 3.4 trillion KRW for rapid liquidity response in emergencies
▲Yuanta Securities=Decided on short-term borrowing of 93.73 billion KRW through a credit line agreement with non-financial institutions for operating funds
▲Hyosung Advanced Materials=Decided on a 33.2 billion KRW debt guarantee for affiliate GST Global GmbH
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
